BioData World Congress 2017 is to be held at the Wellcome Genome Centre, Cambridge UK, where a vibrant ecosystem of bioinformaticians and research scientists has evolved following the announcement of the results from the Human Genome Project in 2003.
Since those early days the volume and complexity of multi-omics data being generated and shared by international scientists has created huge challenges for data management infrastructures.
At the conference, Dr Misha Kapushesky, CEO of Genestack, will discuss learning points that the company has gained from building secure, flexible infrastructures that optimise collaboration between pharmaceutical companies and research institutes.
BioData World Congress 2017 is held with the support of the Sanger Institute, the European Bioinformatics Institute, the Global Alliance for Genomics and Health, and the Pistoia Alliance.
The organisers explain that the event “aims to showcase innovation, demonstrate success and break through the obstacles and barriers to ensure that the innovations in genomics get to the patient with speed and efficiency.
“This event will push the boundaries in order to realise the power of big data in precision medicine.”
Dr Kapushesky will be talking at the upcoming BioData Congress 2017 on 2nd-3rd November 2017 at the Wellcome Genome Campus, Cambridge UK. He will be discussing “Do you have what it takes to build a biodata ecosystem for your enterprise?” on Day 2 at 14.25.